Cymabay Therapeutics Inc盘中异动临近收盘股价大跌5.03%报23.22美元

自选股智能写手01-11

北京时间2024年01月11日04时41分，Cymabay Therapeutics Inc（CBAY.us）股票出现异动，股价急速下挫5.03%。截至发稿，该股报23.22美元/股，成交量84.2405万股，换手率0.74%，振幅5.52%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-33.88百万美元，每股收益-0.32美元，毛利-215000.00美元，市盈率-25.01倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2402343406?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-01-11 04:41","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2402343406","market":"us","top_or_hot":-1,"title":"Cymabay Therapeutics Inc盘中异动 临近收盘股价大跌5.03%报23.22美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年01月11日04时41分，Cymabay Therapeutics Inc（CBAY.us）股票出现异动，股价急速下挫5.03%。截至发稿，该股报23.22美元/股，成交量84.2405万股，换手率0.74%，振幅5.52%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-33.88百万美元，每股收益-0.32美元，毛利-215000.00美元，市盈率-25.01倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401110441357a3a0c8d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cymabay Therapeutics Inc盘中异动 临近收盘股价大跌5.03%报23.22美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCymabay Therapeutics Inc盘中异动 临近收盘股价大跌5.03%报23.22美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-01-11 04:41 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401110441357a3a0c8d&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年01月11日04时41分，Cymabay Therapeutics Inc（CBAY.us）股票出现异动，股价急速下挫5.03%。截至发稿，该股报23.22美元/股，成交量84.2405万股，换手率0.74%，振幅5.52%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-33.88百万美元，每股收益-0.32美元，毛利-215000.00美元，市盈率-25.01倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401110441357a3a0c8d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CBAY","symbol_name":"CymaBay Therapeutics Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401110441357a3a0c8d&s=b","article_id":"2402343406","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401110441357a3a0c8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2402343406","pubTimestamp":1704919294,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年01月11日04时41分，Cymabay Therapeutics Inc股票出现异动，股价急速下挫5.03%。截至发稿，该股报23.22美元/股，成交量84.2405万股，换手率0.74%，振幅5.52%。Cymabay Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.28%。Cymabay Therapeutics Inc公司简介：CymaBay Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为肝病和其他医疗需求未得到满足的慢性病患者开发创新疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"CBAY":"CymaBay Therapeutics Inc.","BK4007":"制药"},"translate_title":"Cymabay Therapeutics Inc. shares fell 5.03 percent to $23.22 near the close","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CBAY":0.9},"content_text":"北京时间2024年01月11日04时41分，Cymabay Therapeutics Inc（CBAY.us）股票出现异动，股价急速下挫5.03%。截至发稿，该股报23.22美元/股，成交量84.2405万股，换手率0.74%，振幅5.52%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-33.88百万美元，每股收益-0.32美元，毛利-215000.00美元，市盈率-25.01倍。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Cymabay Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 (To Pur Com)、Surrozen Inc C/Wts 01/08/2031 (To Pur Com)、Effector Therapeutics Inc C/Wts 31/12/2025 (To Pur Com)涨幅较大，Clearmind Medicine Inc、Neximmune Inc、安皮奥制药较为活跃，换手率分别为2687.58%、318.96%、237.23%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 (To Pur Com)、Revolution Medicines Inc C/Wts  (To Pur Com)、Sana Biotechnology Inc，振幅分别为243.90%、121.17%、77.40%。Cymabay Therapeutics Inc公司简介：CymaBay Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为肝病和其他医疗需求未得到满足的慢性病患者开发创新疗法。 其在研产品包括两个临床阶段候选产品：seladelpar（一种 PPARd 激动剂）和 MBX-2982（一种 GPR119 激动剂）。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2402343406"}

Cymabay Therapeutics Inc盘中异动 临近收盘股价大跌5.03%报23.22美元

精彩评论

Cymabay Therapeutics Inc盘中异动临近收盘股价大跌5.03%报23.22美元